Announcements Trials
Browse Landscape

Phase

Phase NA 25Phase 2 9Phase EARLY_PHASE1 3Phase 4 3Phase 3 3Phase 1 2Phase 2/3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis Vulgaris 1

Interventions

pembrolizumab 409Cyclophosphamide 398Carboplatin 307Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 209Bevacizumab 207fludarabine 195Docetaxel 186Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 121Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Probiotics × Clear all
NCT05254249 2022-02-24

Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris

Dr. Soetomo General Hospital

Phase 1/2 Unknown
75 enrolled

Psoriasis Vulgaris

Data powered by HemOnc (CC BY 4.0) Colophon âš¡